Needle Free Injection System Market Forecast 2023 - 2030

By Product :

The product segment is categorized into fillable and prefilled. In 2022, the fillable segment accounted for the highest market share and is expected to grow at the fastest CAGR in the overall needle free injection system market. The fillable based needle free injection system is widely demanded due to its environmentally friendly nature. Moreover, fillable products have wide availability and a high adoption rate in the market. For instance, in May 2022, Terumo Pharmaceutical Solutions, manufacturer of injection, primary container, and infusion therapy devices, launched pre-fillable polymer syringe for the main application of ophthalmic drugs and high-value drug applications such as intravitreal injection. Hence, due to advanced product launches by the key players in the market, the fillable segment is foreseeing significant growth in the needle free injection system market.

By Usability :

The usability segment is categorized into disposable and reusable. In 2022, disposable segment accounted for the highest market share and is expected to grow at the fastest CAGR in the overall needle free injection system market. These types of needles are widely demanded to take blood samples and vaccines. For instance, in August 2021, Zydus Cadila received Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D. It is the First Plasmid DNA COVID-19 Vaccine Delivered Exclusively with the PharmaJet Needle-free Injection System. Thus the the aforementioned increases the growth of the disposable segment.

By Application :

The application segment is categorized into vaccine delivery, insulin delivery, pain management, and others. In 2022, the vaccine delivery segment accounted for the highest market share of 41.05% in the needle free injection system market due to rising cases of chronic disease globally. The rise in chronic conditions and infectious diseases across the globe has led to high demand for vaccination. Also, from the time of COVID-19, the demand for self-injectable devices and mass vaccination has increased in different regions globally. Moreover, the increasing vaccination demand for pediatric patients and mass vaccination campaigns are acting as catalysts for the growth of needle free injection system market. For instance, according to the report published by UNICEF in July 2023, vaccination rates are increasing positively from 81% in 2021 to 83% in 2022. The report also mentions the global coverage rate for the third dose of the DTP vaccine increased from 81 % in 2021 to 84% in 2022. Hence, increasing vaccination programs is driving the growth of vaccine delivery in needle free injection system market.

Moreover, the pain management segment is expected to grow at the fastest CAGR in the overall needle free injection system market during the forecast period. This is owing to rising cases of medical conditions such as arthritis, pain disorders, and migraine globally. Also, increasing cases of chronic pain, migraine, tension headache, and cluster headache, among others are expected to foster the growth of the pain management segment during the forecast period.

Get More Information

Download Sample Report

By End User :

The end user segment is categorized into hospitals & clinics, home care settings, research laboratories, and others. In 2022, the hospitals & clinics accounted for the highest market share and is expected to grow at the fastest CAGR in the overall needle free injection system market. Needle free injections have wide usage in hospitals in operation theatres, outpatient departments, emergency rooms, and others. The rising number of hospitals across the globe coupled with the rising demand for vaccination in hospitals globally is driving segmental growth. Moreover, technological advancement such as advanced medical treatments in private hospitals globally is acting as a catalyst for the segment growth. For instance, according to Invest India, the hospital industry in India is expected to reach around USD 132 Billion by the end of the year 2023 from USD 61.8 Billion in 2017, growing at a CAGR of around 16%. Thus, the increasing number of hospitals is directly influencing the growth of hospitals & clinics globally

By Region :

The regional segment includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

In 2022, North America accounted for the highest market share of 36.10% and was valued at USD 5,898.74 million and is expected to reach USD 17,586.99 million in 2030. In the North America region, the U.S. accounted for the highest market share of 65.15% during the base year 2022. The increasing demand for needle free injection system is attributed to the high presence of market players, coupled with highly developed healthcare systems in North America, specifically in the U.S. and Canada. Also, the rising number of chronic and lifestyle-associated diseases is significantly influencing the market growth of needle free injection system in North America. For instance, according to a recent report by the Centers for Disease Control and Prevention, chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death in the U.S. These diseases have accounted for approximately USD 4.1 trillion in annual healthcare costs. Thus, the increasing number of chronic patients in the U.S. is significantly impacting a larger growth rate in the needle free injection system market.

Moreover, Asia Pacific is expected to grow at the fastest CAGR of 15.4% during the forecast period due to favorable government initiatives for the use of medical devices in countries such as India and China. Moreover, the rising healthcare expenditure and increase in private sector hospitals and clinics is contributing to the growth of needle free injection system market in the region. For instance, in 2023, according to an article by the Ministry of Health and Family Welfare, the Union Government's share accounted for 12.14% of the current health expenditure. As a result, the increasing government expenditure in the healthcare sector is anticipated to boost the market growth during the forecast period.